3.2.1.17	cell wall of Micrococcus lysodeikticus + H2O	-	
3.2.1.17	additional information	AcmB expression is modulated during cell growth, AcmB is not involved in cell separation but contributes to cellular autolysis	
3.2.1.17	additional information	LycGL may be involved in antibacterial immune response activated by bacterial vaccine as an accute-phase molecule	
3.2.1.17	additional information	enzyme exhibits potent lytic activities against fish pathogens	
3.2.1.17	additional information	enzyme lyses specifically Thermus aquaticus cells, with 79% activity on Thermus fhermophilus HB8 and 76% activity on Thermus filífformis	
3.2.1.17	additional information	lysozyme and its derived peptides are able to bind biotin-labeled pUC19 plasmid DNA. The nonpeptide RAWVAWRNR, amino acids 107-115 of lysozyme, binds DNA with a KD value comparable to histones. Binding results in conformational changes. Lysozyme may represent part of the innate immune system with a very broad protective spectrum	
3.2.1.17	additional information	recombinant enzyme displays inhibitory activity against Gram-negative and Gram-positive bacteria	
3.2.1.17	additional information	antimicrobial activities of lysozyme derivatives are tested against Staphylococcus aureus ATCC 121002 and Escherichia coli ATCC 29998, as gram-positive and gram-negative representatives, respectively. The enzyme is activa against Staphylococcus aureus, but only poorly against Escherichia coli, overview	
3.2.1.17	additional information	comparison of the lytic activities of three recombinant g-type lysozyme isozymes, OHLysG1, OHLysG2 and OHLysG3 against Aeromonas hydrophila, Aeromonas sobria, Vibrio fluvialis, Micrococcus lysodeikticus and Escherichia coli, overview	
3.2.1.17	additional information	dry-heated lysozyme has increased activity against Escherichia coli membranes compared to native lysozyme, overview. The latter only delays bacterial growth, while dry-heated lysozyme causes an early-stage population decrease. Escherichia coli K-12 strain MG1655 Ivy::Cm, which lacks the periplasmic lysozyme inhibitor Ivy, is utilized	
3.2.1.17	additional information	recombinant CC-Lys-g produced in Escherichia coli expression system exhibits significant lytic activity against Gram-positive Micrococcus lysodeikticus and Gram-negative Aeromonas hydrophila	
3.2.1.17	additional information	the destabilase-lysozyme is a bifunctional enzyme, which combines isopeptidase and lysozyme activities	
3.2.1.17	additional information	the enzyme shows antibacterial activity by growth inhibition of a target organism Planococcus citreus	
3.2.1.17	additional information	the recombinant enzyme displays the lytic activity of g-type lysozyme with other organisms against Micrococcus lysodikicus	
3.2.1.17	additional information	the enzyme exhibits bacteriolytic activity against Escherichia coli, Aeromonas hydrophila, Staphyloccocus aureus, Bacillus subtilis, Streptococcus sp. and Staphylococcus epidermidis	
3.2.1.17	additional information	cleaves the glycosidic linkage between N-acetylmuramoyl and N-acetylglucosaminyl residues	
3.2.1.17	peptidoglycan + H2O	-	
3.2.1.17	peptidoglycan + H2O	anti-tumor activity	
3.2.1.17	peptidoglycan + H2O	involvement in host defence	
3.2.1.17	peptidoglycan + H2O	anti-metastatic activity	
3.2.1.17	peptidoglycan + H2O	cell lysis from within, at the end of latent period, cell lysis from without, at the beginning of infection	
3.2.1.17	peptidoglycan + H2O	digestive enzyme	
3.2.1.17	peptidoglycan + H2O	the enzyme cleaves the beta-(1,4)-glycosidic bond between N-acetylmuramic acid and N-acetylglucosamine of bacterial cell wall peptidoglycans